Section Arrow
AXDX.NASDAQ
- Accelerate Diagnostics
(Financial Status)
Quotes are at least 15-min delayed:2024/05/15 13:13 EDT
Last
 0.91
0 (0.00%)
Day High 
0.93 
Prev. Close
0.91 
1-M High
1.01 
Volume 
4.80K 
Bid
0.89
Ask
0.93
Day Low
0.8903 
Open
0.93 
1-M Low
0.73 
Market Cap 
19.71M 
Currency USD 
P/E -- 
%Yield
10-SMA 0.91 
20-SMA 0.89 
50-SMA 0.94 
52-W High 11.9 
52-W Low 0.73 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-4.94/--
Enterprise Value
56.65M
Balance Sheet
Book Value Per Share
-0.92
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
12.06M
Operating Revenue Per Share
0.54
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
SINTSiNtx Technologies0.1267+0.0717+130.36%-- 
PACBPacific Biosciences of California2.15-0.08-3.59%-- 
ZOMZomedica Corp0.1657+0.0196+13.42%-- 
AEMDAethlon Medical0.449-0.4011-47.18%-- 
CATXPerspective Therapeutics1.665-0.095-5.40%-- 
Quotes are at least 15-min delayed:2024/05/15 13:13 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Accelerate Diagnostics Inc is an in vitro diagnostics company that specializes in rapid diagnostics for infectious pathogens. The firm's core platform, the Accelerate ID/AST System, determines whether live bacterial or fungal cells in a patient sample are susceptible to a particular antibiotic. This test is performed on pathogens that are commonly associated with serious infections and can deliver results more quickly than traditional methods, such as bacterial culturing. The system can analyze a positive blood culture sample in approximately five hours, which is faster than traditional testing techniques. The company earns majority of its revenue from domestic market.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.